MEDIGENE N (MDG1.SG)
MEDIGENE N (MDG1.SG) operates in Diversified Metals & Mining.
MEDIGENE N (MDG1.SG) (MDG1) - Total Assets
Latest total assets as of June 2024: €28.81 Million EUR
Based on the latest financial reports, MEDIGENE N (MDG1.SG) (MDG1) holds total assets worth €28.81 Million EUR as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MEDIGENE N (MDG1.SG) - Total Assets Trend (2016–2023)
This chart illustrates how MEDIGENE N (MDG1.SG)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
MEDIGENE N (MDG1.SG) - Asset Composition Analysis
Current Asset Composition (December 2023)
MEDIGENE N (MDG1.SG)'s total assets of €28.81 Million consist of 57.2% current assets and 42.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 27.4% |
| Accounts Receivable | €416.00K | 1.3% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €9.85 Million | 31.1% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how MEDIGENE N (MDG1.SG)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MEDIGENE N (MDG1.SG)'s current assets represent 57.2% of total assets in 2023, a decrease from 57.3% in 2016.
- Cash Position: Cash and equivalents constituted 27.4% of total assets in 2023, up from 13.1% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, unchanged from 31.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 31.1% of total assets.
MEDIGENE N (MDG1.SG) Competitors by Total Assets
Key competitors of MEDIGENE N (MDG1.SG) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
MEDIGENE N (MDG1.SG) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - MEDIGENE N (MDG1.SG) generates 0.19x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - MEDIGENE N (MDG1.SG) is currently not profitable relative to its asset base.
MEDIGENE N (MDG1.SG) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.39 | 4.74 | 6.04 |
| Quick Ratio | 2.39 | 4.74 | 6.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €9.10 Million | € 22.03 Million | € 58.12 Million |
MEDIGENE N (MDG1.SG) - Advanced Valuation Insights
This section examines the relationship between MEDIGENE N (MDG1.SG)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -38.6% |
| Total Assets | €31.72 Million |
| Market Capitalization | $280.86 USD |
Valuation Analysis
Below Book Valuation: The market values MEDIGENE N (MDG1.SG)'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: MEDIGENE N (MDG1.SG)'s assets decreased by 38.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for MEDIGENE N (MDG1.SG) (2016–2023)
The table below shows the annual total assets of MEDIGENE N (MDG1.SG) from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €31.72 Million | -38.63% |
| 2022-12-31 | €51.68 Million | -13.10% |
| 2021-12-31 | €59.47 Million | -20.44% |
| 2020-12-31 | €74.75 Million | -31.56% |
| 2019-12-31 | €109.22 Million | -15.72% |
| 2018-12-31 | €129.59 Million | +15.77% |
| 2017-12-31 | €111.94 Million | +0.20% |
| 2016-12-31 | €111.72 Million | -- |